Table of Contents

company-logo

AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Uppsala, Sweden.

AroCell Dividend Announcement

• AroCell does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on AroCell dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

AroCell Dividend Yield

AroCell current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing AroCell stock? Use our calculator to estimate your expected dividend yield:

AroCell Financial Ratios

P/E ratio-1.91
PEG ratio-0.17
P/B ratio0.74
ROE-34.43%
Payout ratio0.00%
Current ratio5.05
Quick ratio4.52
Cash Ratio3.41

AroCell Dividend FAQ

Does AroCell stock pay dividends?
AroCell does not currently pay dividends to its shareholders.
Has AroCell ever paid a dividend?
No, AroCell has no a history of paying dividends to its shareholders. AroCell is not known for its dividend payments.
Why doesn't AroCell pay dividends?
There are several potential reasons why AroCell would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will AroCell ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While AroCell has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is AroCell a dividend aristocrat?
AroCell is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AroCell a dividend king?
AroCell is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AroCell a dividend stock?
No, AroCell is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy AroCell stocks?
To buy AroCell you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy AroCell stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.